北京百奥药业

Beijing Baiao Pharmaceuticals is a Chinese biopharmaceutical company specializing in the research, development, and manufacturing of cardiovascular and cerebrovascular medicines. Founded in 1995 and based in Beijing, the company is best known for its flagship product, Boluoke (Lumbrokinase), a potent fibrinolytic enzyme used to treat ischemic stroke and other thrombotic conditions. Baiao operates modern GMP-certified production facilities and maintains a diverse portfolio that includes both biological extracts and small molecule generics. As a key subsidiary of Beijing Zhongguancun Science-Tech Development Co., Ltd., the company focuses on integrating traditional biochemical extraction with modern pharmaceutical technology. Their product line extends to treatments for hypertension, diabetes, and various metabolic disorders, serving a broad patient base in China and international markets.